FAS mutation varies in EMZL of different sites

Keying Chen; Maria‐Myrsini Tzioni; Zi Chen; Ewelina Madej; Ming‐Qing Du

doi:10.1080/10428194.2026.2707443

July 27, 2026Leukemia & lymphoma/Leukemia and lymphoma

FAS mutation varies in EMZL of different sites

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to explore the variability of FAS mutations in EMZL occurring in different anatomical sites.
Analyzed FAS mutation rates in EMZL samples from multiple extranodal sites.
Utilized chronic inflammation assessments to correlate with mutation presence.
Evaluated the genetic characteristics of B-cell malignancies involved.
FAS mutations were present in varying frequencies across different EMZL sites.
Correlation between chronic inflammation levels and mutation rates was established.
Specific site characteristics impacted the types of mutations observed.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Examines FAS mutation differences in EMZL across various sites, suggesting site-specific influences.

Abstract

Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (EMZL) is an indolent low-grade B-cell malignancy that arises at diverse extranodal sites, driven by distinct chronic inflamma...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/6a69a27dc8da07d9defa5df8 https://doi.org/10.1080/10428194.2026.2707443

View at Publisher

Ask AI

Bookmark

Share

FAS mutation varies in EMZL of different sites

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

FAS mutation varies in EMZL of different sites

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading